Stoke Therapeutics logo

Stoke Therapeutics share price today

(STOK)

Stoke Therapeutics share price is $11.02 & ₹945.63 as on 7 Jan 2025, 2.30 'hrs' IST

$11.02

-0.47

(-4.09%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Stoke Therapeutics share price in Dollar and Rupees. Guide to invest in Stoke Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Stoke Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Stoke Therapeutics share price movements

  • Today's Low: $11.00
    Today's High: $11.62

    Day's Volatility :5.29%

  • 52 Weeks Low: $4.09
    52 Weeks High: $17.58

    52 Weeks Volatility :76.73%

Stoke Therapeutics Returns

PeriodStoke TherapeuticsSector (Health Care)Index (Russel 2000)
3 Months
-6.43%
-8.4%
0.0%
6 Months
-14.13%
-3.8%
0.0%
1 Year
115.98%
-0.1%
0.0%
3 Years
-40.5%
2.9%
-19.8%

Stoke Therapeutics Key Statistics

in dollars & INR

Previous Close
$11.49
Open
$11.51
Today's High
$11.615
Today's Low
$11.0
Market Capitalization
$584.2M
Today's Volume
$520.2K
52 Week High
$17.58
52 Week Low
$4.09
Revenue TTM
$16.7M
EBITDA
$-115.0M
Earnings Per Share (EPS)
$-2.08
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-52.06%

How to invest in Stoke Therapeutics from India?

It is very easy for Indian residents to invest directly in Stoke Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Stoke Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Stoke Therapeutics or STOK on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Stoke Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Stoke Therapeutics shares which would translate to 0.078 fractional shares of Stoke Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Stoke Therapeutics, in just a few clicks!

Returns in Stoke Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Stoke Therapeutics investment value today

Current value as on today

₹2,10,365

Returns

₹1,10,365

(+110.37%)

Returns from Stoke Therapeutics Stock

₹1,07,143 (+107.14%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Stoke Therapeutics

-8%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Stoke Therapeutics on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -8% less investors are searching Stoke Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Stoke Therapeutics

  • Skorpios Trust

    16.81%

  • BlackRock Inc

    10.21%

  • Redmile Group, LLC

    8.90%

  • RTW INVESTMENTS, LLC

    8.78%

  • Baker Bros Advisors LP

    8.25%

  • Morgan Stanley - Brokerage Accounts

    7.94%

Analyst Recommendation on Stoke Therapeutics

Buy

    86%Buy

    13%Hold

    0%Sell

Based on 15 Wall street analysts offering stock ratings for Stoke Therapeutics(by analysts ranked 0 to 5 stars)

Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
12
12
Hold
2
3
3
Sell
0
0
0

Analyst Forecast on Stoke Therapeutics

What analysts predicted

Upside of 104.17%

Current:

$11.02

Target:

$22.50

Insights on Stoke Therapeutics

  • Price Movement

    In the last 1 year, STOK stock has moved up by 118.4%
  • Increasing Revenue

    Revenue is up for the last 4 quarters, 2.80M → 4.89M (in $), with an average increase of 15.9% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -25.69M → -26.43M (in $), with an average decrease of 2.9% per quarter
  • STOK vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 100.1%

Stoke Therapeutics Technicals Summary

Sell

Neutral

Buy

Stoke Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Stoke Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Stoke Therapeutics
-16.5%
-14.13%
115.98%
-40.5%
-54.76%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Stoke Therapeutics
NA
NA
NA
-2.04
-0.52
-0.28
NA
4.38
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Stoke Therapeutics
Buy
$584.2M
-54.76%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Stoke Therapeutics

stoke is developing antisense oligonucleotide medicines that target rna splicing to increase gene expression for the treatment of severe genetic diseases.
Organization
Stoke Therapeutics
Employees
110
CEO
Dr. Edward M. Kaye M.D., Ph.D.
Industry
Health Technology

Management People of Stoke Therapeutics

NameTitle
Dr. Edward M. Kaye M.D., Ph.D.
CEO & Director
Dr. Adrian R. Krainer Ph.D.
Co-Founder & Independent Director
Dr. Barry S. Ticho FACC, M.D., Ph.D.
Chief Medical Officer
Ms. Isabel Aznarez Ph.D.
Co-Founder, Head of Research & Senior VP
Mr. Thomas Edward Leggett
Chief Financial Officer
Mr. Eric Rojas
Head of Investor Relations
Mr. Jonathan Allan J.D.
Corporate Secretary & General Counsel
Ms. Dawn Kalmar
Chief Communications Officer
Ms. Joan Wood
Chief Human Resources Officer
Ms. Shamim Ruff M.S.
Senior VP of Quality & Chief Regulatory Affairs Officer

Important FAQs about investing in Stoke Therapeutics from India :

What is Stoke Therapeutics share price today?

Stoke Therapeutics share price today stands at $11.02, Open: $11.51 ; Previous Close: $11.49 ; High: $11.62 ; Low: $11.00 ; 52 Week High: $17.58 ; 52 Week Low: $4.09. The stock opens at $11.51, after a previous close of $11.49. The stock reached a daily high of $11.62 and a low of $11.00, with a 52-week high of $17.58 and a 52-week low of $4.09.

Can Indians buy Stoke Therapeutics shares?

Yes, Indians can invest in the Stoke Therapeutics (STOK) from India.

With INDmoney, you can buy Stoke Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Stoke Therapeutics at zero transaction cost.

How can I buy Stoke Therapeutics shares from India?

It is very easy to buy Stoke Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Stoke Therapeutics be purchased?

Yes, you can buy fractional shares of Stoke Therapeutics with INDmoney app.

What are the documents required to start investing in Stoke Therapeutics stocks?

To start investing in Stoke Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Stoke Therapeutics

Today’s highest price of Stoke Therapeutics (STOK) is $11.62.

Today’s lowest price of Stoke Therapeutics (STOK) is $11.00.

What is today's market capitalisation of Stoke Therapeutics

Today's market capitalisation of Stoke Therapeutics STOK is 584.2M

What is the 52 Week High and Low Range of Stoke Therapeutics

  • 52 Week High

    $17.58

  • 52 Week Low

    $4.09

What are the historical returns of Stoke Therapeutics?

  • 1 Month Returns

    -16.5%

  • 3 Months Returns

    -14.13%

  • 1 Year Returns

    115.98%

  • 5 Years Returns

    -54.76%

Who is the Chief Executive Officer (CEO) of Stoke Therapeutics

Dr. Edward M. Kaye M.D., Ph.D. is the current Chief Executive Officer (CEO) of Stoke Therapeutics.